Stay updated on Autologous TILs in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Autologous TILs in Solid Tumors Clinical Trial page.

Latest updates to the Autologous TILs in Solid Tumors Clinical Trial page
- Check5 days agoChange DetectedThe page now displays revision v3.6.2, upgrading from the previous v3.6.0, which indicates a site/build update. There is no visible impact on the study details, eligibility criteria, or other content on the page.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedAdded recruitment status note 'No longer looking for participants' and new help/navigation sections: How to Read a Study Record, Common Questions, and How to Join a Study. Updated the header label from 'Intervention / Treatment' to 'Intervention/Treatment' and replaced the old revision tag with 'Revision: v3.6.0'.SummaryDifference0.3%

- Check27 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, signaling a minor update to the study page without changes to its data.SummaryDifference0.0%

- Check49 days agoChange DetectedNew content adds a concluding statement on events for evaluating study endpoints and expands details about lifileucel-based TIL therapies and their regimens across cohorts. It also updates enrollment numbers (225), location count (34), eligibility criteria, and recruitment status, while removing some contact information and older location listings.SummaryDifference6%

- Check70 days agoChange DetectedThe page’s footer revision/version indicator has been updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check78 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

Stay in the know with updates to Autologous TILs in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Autologous TILs in Solid Tumors Clinical Trial page.